Sangamo Therapeutics Inc (SGMO)

Nov 23, 2024

GSA Capital Partners LLP Sells 587,544 Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) - MarketBeat

Nov 23, 2024

Nov 22, 2024

Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.

Nov 22, 2024

Nov 21, 2024

Sangamo stock climbs 12% post-market on FDA update for ST-503 - MSN

Nov 21, 2024

Nov 20, 2024

Analysts Just Made A Massive Upgrade To Their Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Forecasts - Simply Wall St

Nov 20, 2024

Nov 19, 2024

Sangamo Therapeutics Announces U.S. FDA Clearance of IND Application for ST-503 for the Treatment of Idiopathic Small Fiber Neuropathy, a Type of Chronic Neuropathic Pain - BioSpace

Nov 19, 2024

Nov 19, 2024

Sangamo Therapeutics Gets FDA Clearance for Investigational NDA for Pain Treatment - Marketscreener.com

Nov 19, 2024

Nov 19, 2024

Sangamo's Novel Gene Therapy for Chronic Pain Gets FDA Clearance for Clinical Trials | SGMO Stock News - StockTitan

Nov 19, 2024

Nov 18, 2024

What is HC Wainwright's Forecast for SGMO FY2024 Earnings? - MarketBeat

Nov 18, 2024

Nov 15, 2024

FY2028 Earnings Forecast for SGMO Issued By HC Wainwright - MarketBeat

Nov 15, 2024

Nov 15, 2024

Sangamo Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Nov 15, 2024

Nov 14, 2024

Sangamo Therapeutics (NASDAQ:SGMO) Price Target Raised to $9.00 at Barclays - MarketBeat

Nov 14, 2024

Nov 14, 2024

Sangamo Therapeutics' SWOT analysis: gene therapy firm's stock faces challenges, opportunities - Investing.com Canada

Nov 14, 2024

Nov 13, 2024

Sangamo: Q3 Earnings Snapshot - Marketscreener.com

Nov 13, 2024

Nov 13, 2024

Sangamo Therapeutics (SGMO) Tops Q3 Earnings and Revenue Estimates - MSN

Nov 13, 2024

Nov 13, 2024

Earnings call: Sangamo Therapeutics reports progress in gene therapies By Investing.com - Investing.com Australia

Nov 13, 2024

Nov 13, 2024

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Nov 13, 2024

Earnings call: Sangamo Therapeutics reports progress in gene therapies - Investing.com India

Nov 13, 2024

Nov 13, 2024

Sangamo Therapeutics Inc (SGMO) Q3 2024 Earnings Call Highlights: Strategic Advances and ... By GuruFocus - Investing.com Canada

Nov 13, 2024

Nov 13, 2024

Sangamo Therapeutics Inc (SGMO) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Outlook - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

SGMOSangamo Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 13, 2024

Nov 13, 2024

Sangamo Therapeutics Inc (SGMO) Q3 2024 Earnings Call Highlights: Strategic Advances and ... - Yahoo Finance

Nov 13, 2024

Nov 12, 2024

Sangamo Therapeutics Q3 beats propel stock 5% higher - MSN

Nov 12, 2024

Nov 12, 2024

Sangamo Therapeutics earnings beat by $0.06, revenue topped estimates - Investing.com UK

Nov 12, 2024

Nov 12, 2024

Sangamo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results - Business Wire

Nov 12, 2024

Nov 11, 2024

Sangamo Therapeutics's Earnings Outlook - Benzinga

Nov 11, 2024

Nov 08, 2024

FY2024 Earnings Forecast for SGMO Issued By HC Wainwright - Defense World

Nov 08, 2024

Nov 08, 2024

Gene Therapy Market to Grow by USD 6.74 Billion from 2024-2028, as Rise in Special Drug Designations Drives Demand with AI-Powered Market EvolutionTechnavio - The Malaysian Reserve

Nov 08, 2024

Nov 07, 2024

Equities Analysts Set Expectations for SGMO FY2024 Earnings - MarketBeat

Nov 07, 2024

Nov 07, 2024

Sangamo Therapeutics (NASDAQ:SGMO) Reaches New 12-Month High on Analyst Upgrade - Defense World

Nov 07, 2024

Nov 06, 2024

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences - The Manila Times

Nov 06, 2024

Nov 06, 2024

Sangamo (SGMO) Stock Rally Continues In Pre-Market Ahead of Financial Results Release - Stocks Telegraph

Nov 06, 2024

Nov 05, 2024

Sangamo Therapeutics (SGMO) Set to Announce Quarterly Earnings on Tuesday - MarketBeat

Nov 05, 2024

Nov 05, 2024

Sangamo Therapeutics (NASDAQ:SGMO) Price Target Raised to $10.00 at HC Wainwright - MarketBeat

Nov 05, 2024

Nov 05, 2024

Vanguard Group Inc's Strategic Reduction in Sangamo Therapeutics Inc - GuruFocus.com

Nov 05, 2024

Nov 05, 2024

Sangamo price target raised to $10 from $5 at H.C. Wainwright - TipRanks

Nov 05, 2024

Nov 04, 2024

Parkinson’s Disease Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - Barchart

Nov 04, 2024

Nov 04, 2024

Sangamo Therapeutics Announces Third Quarter 2024 Conference Call and Webcast - StockTitan

Nov 04, 2024

Nov 01, 2024

individual investors who own 55% along with institutions invested in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) saw increase in their holdings value last week - Yahoo Finance

Nov 01, 2024

Nov 01, 2024

Sangamo Therapeutics (NASDAQ:SGMO) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World

Nov 01, 2024

Nov 01, 2024

Sangamo Therapeutics (NASDAQ:SGMO) Stock Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat

Nov 01, 2024

Oct 29, 2024

Gene Therapy Market Detailed Analysis and Forecast to 2031 - InsightAce Analytic

Oct 29, 2024

Oct 26, 2024

StockWatch: Sangamo Shares Surge on Shorter Pathway for Fabry Candidate - Genetic Engineering & Biotechnology News

Oct 26, 2024

Oct 25, 2024

Fabry disease gene therapy study data enough for FDA submission - Fabry Disease News

Oct 25, 2024

Oct 25, 2024

Prime Medicine Spat with Tessera Rumbles on at ESGCT - Genetic Engineering & Biotechnology News

Oct 25, 2024

Oct 25, 2024

Booz Allen Posts Upbeat Q3 Earnings, Joins Deckers Outdoor, Saia, Boyd Gaming And Other Big Stocks Moving Higher On Friday - Benzinga

Oct 25, 2024

Oct 24, 2024

Sangamo Therapeutics' SWOT analysis: genomic medicine stock at crossroads - Investing.com

Oct 24, 2024